Focus
643 results
Sales
Solid +6% growth despite turbulences
Sales: 32.40 billion euros, +6.0% like-for-like[1], +6.0% reported.
Growth in all Divisions with L’Oréal Luxe accelerating a third consecutive quarter, Professional Products keeping the rhythm.
Others
Global Access to Skin Health Observatory to assess 194 nations’ ability to provide vital skin health services to citizens
Others
We invite you to explore the Group’s latest Letter to Shareholders. In addition to our half year results and recent news, we invite you to discover:
how L’Oréal is accelerating its Beauty Tech leadership
the events, visits and meetings strengthening our ties with individual shareholders
Read the letter
Télécharger le pdf
Finance
On Friday, September 13, 2024, Christophe Babule, Chief Financial Officer of L'Oréal, participated in the sixth edition of the Giverny Forum. He joined a roundtable discussion focused on the crucial theme of "Sharing Values", moderated by journalist Adeline Haverland. Joining Mr.
Finance
Tri-party agreement will drive biotech innovation via integrated lab-to-market collaboration
Prizes
L’Oréal has been recognized for its commitment to diversity, equity and inclusion, securing the fifth position globally in this year’s prestigious FTSE Diversity & Inclusion Index Top 100 companies list. L’Oréal is also first among the French companies on the list, out of over 15,500 companies assessed worldwide.
Spotted in the annual report
Every year, L'Oréal's Annual Report offers a deep dive into the heart of our strategy, our commitments, and our ambitions for the future.
Spotted in the annual report
Every year, L'Oréal's Annual Report offers a deep dive into the heart of our strategy, our commitments, and our ambitions for the future.
Others
Test your knowledge on L'Oréal Group, its brands, its initiatives and its financial, social and environmental performance by exploring the latest edition of our annual report!
CLICK HERE TO TAKE THE SUMMER QUIZ
To find out more about the beauty of performance, discover the 2023 Annual Report.
Acquisitions
Inside information
L’ORÉAL GROUPE ACQUIRES A 10% STAKE IN GALDERMA, THE PURE-PLAY DERMATOLOGY LEADER AND ONE OF THE WORLD’S LARGEST PLAYERS IN INJECTABLE AESTHETICS.
THIS INVESTMENT TO BE COMPLEMENTED BY A NEW STRATEGIC SCIENTIFIC PARTNERSHIP BETWEEN L’ORÉAL AND GALDERMA.